Strs Ohio Sells 6,779 Shares of Cardinal Health, Inc. (NYSE:CAH)

Strs Ohio decreased its stake in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 21.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 24,810 shares of the company’s stock after selling 6,779 shares during the quarter. Strs Ohio’s holdings in Cardinal Health were worth $2,500,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Aaron Wealth Advisors LLC boosted its position in shares of Cardinal Health by 1.2% during the fourth quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company’s stock worth $844,000 after acquiring an additional 97 shares during the last quarter. Schechter Investment Advisors LLC boosted its position in shares of Cardinal Health by 4.1% during the fourth quarter. Schechter Investment Advisors LLC now owns 2,480 shares of the company’s stock worth $250,000 after acquiring an additional 98 shares during the last quarter. Cypress Capital Group boosted its position in shares of Cardinal Health by 0.7% during the third quarter. Cypress Capital Group now owns 17,133 shares of the company’s stock worth $1,487,000 after acquiring an additional 111 shares during the last quarter. MBM Wealth Consultants LLC boosted its position in shares of Cardinal Health by 3.7% during the third quarter. MBM Wealth Consultants LLC now owns 3,238 shares of the company’s stock worth $302,000 after acquiring an additional 115 shares during the last quarter. Finally, Monument Capital Management lifted its position in Cardinal Health by 3.0% during the third quarter. Monument Capital Management now owns 4,639 shares of the company’s stock valued at $403,000 after purchasing an additional 136 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

CAH has been the subject of several research reports. Barclays initiated coverage on shares of Cardinal Health in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $117.00 price objective for the company. Leerink Partnrs reiterated an “outperform” rating on shares of Cardinal Health in a research report on Monday, February 26th. SVB Leerink initiated coverage on shares of Cardinal Health in a research report on Monday, February 26th. They set an “outperform” rating and a $125.00 price objective for the company. Argus upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating in a research report on Friday, February 9th. Finally, UBS Group increased their price objective on shares of Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $103.07.

View Our Latest Stock Report on CAH

Cardinal Health Trading Up 2.1 %

Cardinal Health stock opened at $108.19 on Friday. The firm has a 50-day moving average price of $109.59 and a 200-day moving average price of $104.18. The firm has a market capitalization of $26.32 billion, a PE ratio of 42.59, a price-to-earnings-growth ratio of 1.03 and a beta of 0.68. Cardinal Health, Inc. has a 12-month low of $77.56 and a 12-month high of $116.04.

Cardinal Health (NYSE:CAHGet Free Report) last released its earnings results on Thursday, February 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.56 by $0.26. The firm had revenue of $57.45 billion during the quarter, compared to analyst estimates of $57.02 billion. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The business’s revenue was up 11.6% on a year-over-year basis. During the same quarter last year, the business earned $1.32 EPS. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.28 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were paid a $0.5006 dividend. This represents a $2.00 annualized dividend and a yield of 1.85%. The ex-dividend date of this dividend was Thursday, March 28th. Cardinal Health’s dividend payout ratio is presently 78.74%.

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Articles

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.